Literature DB >> 23440610

Incorporating data from various trial designs into a mixed treatment comparison model.

Susanne Schmitz1, Roisin Adams, Cathal Walsh.   

Abstract

Estimates of relative efficacy between alternative treatments are crucial for decision making in health care. Bayesian mixed treatment comparison models provide a powerful methodology to obtain such estimates when head-to-head evidence is not available or insufficient. In recent years, this methodology has become widely accepted and applied in economic modelling of healthcare interventions. Most evaluations only consider evidence from randomized controlled trials, while information from other trial designs is ignored. In this paper, we propose three alternative methods of combining data from different trial designs in a mixed treatment comparison model. Naive pooling is the simplest approach and does not differentiate between-trial designs. Utilizing observational data as prior information allows adjusting for bias due to trial design. The most flexible technique is a three-level hierarchical model. Such a model allows for bias adjustment while also accounting for heterogeneity between-trial designs. These techniques are illustrated using an application in rheumatoid arthritis.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  hierarchical modelling; mixed treatment comparison; multiple treatments meta-analysis; network meta-analysis; observational data; rheumatoid arthritis

Mesh:

Year:  2013        PMID: 23440610     DOI: 10.1002/sim.5764

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  30 in total

Review 1.  Harms of off-label erythropoiesis-stimulating agents for critically ill people.

Authors:  Bita Mesgarpour; Benedikt H Heidinger; Dominik Roth; Susanne Schmitz; Cathal D Walsh; Harald Herkner
Journal:  Cochrane Database Syst Rev       Date:  2017-08-25

2.  Bayesian hierarchical methods for meta-analysis combining randomized-controlled and single-arm studies.

Authors:  Jing Zhang; Chia-Wen Ko; Lei Nie; Yong Chen; Ram Tiwari
Journal:  Stat Methods Med Res       Date:  2018-02-13       Impact factor: 3.021

3.  Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity.

Authors:  Susanne Schmitz; Tatjana T Makovski; Roisin Adams; Marjan van den Akker; Saverio Stranges; Maurice P Zeegers
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

Review 4.  Endovascular Therapy for Symptomatic Intracranial Artery Stenosis: a Systematic Review and Network Meta-analysis.

Authors:  Tao Wang; Kun Yang; Xiao Zhang; Jichang Luo; Ran Xu; Xue Wang; Yutong Yang; Xuesong Bai; Yan Ma; Yuxiang Yan; Liqun Jiao
Journal:  Transl Stroke Res       Date:  2022-02-12       Impact factor: 6.800

Review 5.  Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis.

Authors:  Bita Mesgarpour; Benedikt H Heidinger; Michael Schwameis; Calvin Kienbacher; Cathal Walsh; Susanne Schmitz; Harald Herkner
Journal:  Intensive Care Med       Date:  2013-08-09       Impact factor: 17.440

6.  Classifying information-sharing methods.

Authors:  Georgios F Nikolaidis; Beth Woods; Stephen Palmer; Marta O Soares
Journal:  BMC Med Res Methodol       Date:  2021-05-22       Impact factor: 4.615

7.  Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension.

Authors:  Howard H Z Thom; Gorana Capkun; Annamaria Cerulli; Richard M Nixon; Luke S Howard
Journal:  BMC Med Res Methodol       Date:  2015-04-12       Impact factor: 4.615

8.  Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.

Authors:  Chris Cameron; Bruce Fireman; Brian Hutton; Tammy Clifford; Doug Coyle; George Wells; Colin R Dormuth; Robert Platt; Sengwee Toh
Journal:  Syst Rev       Date:  2015-11-05

9.  Checking whether there is an increased risk of post-transplant lymphoproliferative disorder and other cancers with specific modern immunosuppression regimens in renal transplantation: protocol for a network meta-analysis of randomized and observational studies.

Authors:  Brian Hutton; Lawrence Joseph; Fatemeh Yazdi; Jennifer Tetzlaff; Mona Hersi; Madzouka Kokolo; Nicolas Fergusson; Alexandria Bennett; Chieny Buenaventura; Dean Fergusson; Andrea Tricco; Sharon Strauss; David Moher; Greg Knoll
Journal:  Syst Rev       Date:  2014-02-22

10.  A process for assessing the feasibility of a network meta-analysis: a case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer.

Authors:  Shannon Cope; Jie Zhang; Stephen Saletan; Brielan Smiechowski; Jeroen P Jansen; Peter Schmid
Journal:  BMC Med       Date:  2014-06-05       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.